KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • PAVIA

    PAVIA (PhArmaco Vigilance Africa) is an EDCTP-funded project led by Amsterdam Institute for Global Health and Development (AIGHD) with KNCV…

    Lees meer
  • 14/06/2020

    KNCV Tuberculosis Foundation sounds the alarm: COVID-19 will cause even more TB deaths

    The coronavirus has grabbed the attention of the world. Yet with 4,000 deaths a day worldwide, tuberculosis (TB) is holding…

    Lees meer
  • 28/05/2020

    Executive Director Kitty van Weezenbeek leaves KNCV

    Kitty van Weezenbeek has said goodbye as executive director of KNCV Tuberculosis Foundation. After having held this position for seven…

    Lees meer
  • 28/05/2020

    Looking back at five successful years of Challenge TB

    The KNCV-led, USAID-funded Challenge TB (CTB) project operated from 2014 to 2019 in 24 countries and two regions. The overall…

    Lees meer
  • 08/05/2020

    Martin Boeree has been appointed professor

    Effective 1 April 2020, Martin Boeree has been appointed professor of Clinical Tuberculosis and other Mycobacterial Diseases at Radboud University/Radboud…

    Lees meer
  • 01/05/2020

    Dr. Mustapha Gidado becomes acting interim Executive Director of KNCV

    We are very pleased to announce that from 1 May 2020 onwards, Dr. Mustapha Gidado is acting as interim Executive…

    Lees meer
  • 26/03/2020

    Professor John Murray remembered

    We received the sad news that KNCV’s friend and Union hero Professor John Murray passed away of acute respiratory failure…

    Lees meer
  • 24/03/2020

    World TB Day: Together we fight TB and the Coronavirus

    Today – on World TB Day – KNCV Tuberculosis Foundation (KNCV) sends a special message of support to everyone worldwide…

    Lees meer
  • 20/02/2020

    Kitty van Weezenbeek appointed as WHO Director Surveillance, Prevention and Control of AMR

    As of 1 May 2020, the current director of KNCV Tuberculosis Foundation, Kitty van Weezenbeek, will be appointed Director Surveillance,…

    Lees meer
  • 20/02/2020

    PDPs show the value of purpose driven R&D

    KNCV Tuberculosis Foundation looks back at a stimulating dialogue and sharing of good practices during the Product Development Partnerships (PDPs)…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.